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ABSTRACT 
The aim of this study was to evaluate the effect of the mechanical implantation of a MyoRing in patients with severe 
keratoconus and high myopia. The study involved 32 eyes of 32 patients (14 men and 18 women; mean age: 29.6 ± 6.7; age 
range: 20 – 44). The patients underwent MyoRing implantation with mechanical dissection using a Pocket Maker 
microkeratome, and outcomes were assessedat3 months after surgery. The main outcome measures were uncorrected and 
corrected distance visual acuity (UDVA and CDVA, both in Logarithm of the Minimum Angle of Resolution [logMAR] units), 
manifest refraction, and keratometry readings. There was a significant improvement in the UDVA, from 1.14 ± 0.32 to 0.35 ± 
0.24 (P ˂ 0.001), and in the CDVA, from 0.47 ± 0.20 to 0.22 ± 0.15 (P ˂ 0.001). There was also a significant improvement in 
the spherical equivalent refractive error (-10.51 ± 2.81 D to -1.32 ± 2.29 D) (P ˂ 0.001). There was a significant decrease of 
manifest refraction in the mean sphere and cylinder of 7.70 and 2.6 D, respectively (P < 0.001). Furthermore, with regard to 
corneal topography, there was a significant reduction of 3.55 D (P ˂ 0.001) in the mean keratometry reading. The results 
show that the mechanical implantation of a MyoRing is effective for the correction of myopia in patients with keratoconus 
and high myopia. 
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Introduction 
Keratoconus is a non-inflammatory progressive corneal 
ectatic disorder that is often bilateral (though 
asymmetrical) and can induce irregular astigmatism with 
or without myopia (1, 2). It can cause mild to severe 
vision impairment. The prevalence of keratoconus in Iran 
is reported to be 0.76 – 3.3%, which is higher than the 
global average (3, 4). Various treatments have been used 
for the disease. Traditionally, glasses and contact lenses 
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were used in the early stages of the disease, and corneal 
transplants were used in severe to advanced cases (5, 6). 
However, corneal transplants have limitations(7). In 
recent years, new surgical alternatives have been 
developed. For example, collagen cross-linking can be 
used to strengthen the cornea and prevent progression 
of the disease (8, 9). In addition, intrastromal corneal ring 
segments can be used to decrease astigmatism through 
an arc-shortening effect of the corneal lamellae that 
produces a flattening the central cornea (10, 11). The 
advantages of using ring segments within the corneal 
stroma include safety, reversibility, and stability without 
impairment of the optic axis (12, 13). 
Myopia is one of the most common manifestations of 
keratoconus. Usually, the severity of myopia is related to 
the severity of keratoconus. However, the usual 
treatments for myopia, such as photorefractive 
keratectomy (14), epikeratophakia, (15), and laser-
assisted in situ keratomileusis (16), are not suitable for 
patients with keratoconus. Moreover, there is a new 
treatment option that involves using a corneal 
intrastromal implantation system (CISIS). This treatment 
involves a full-ring flexible implant known as a MyoRing 
(DIOPTEX GmbH, Linz, Austria) that is implanted into a 
corneal pocket. It is not only effective for treating 
keratoconus, but can also be effective for treating 
moderate to high myopia (17-20). As there have been no 
studies on Iranian patients with keratoconus and high 
myopia, this study was performed to evaluate the 
effectiveness of the MyoRing implantation on visual 
acuity and refraction in patients with keratoconus and 
high myopia in Iran. 
METHODS 
Study Subjects 
The study involved 32 eyes of 32 patients with 
keratoconus and high myopia who underwent MyoRing 
implantation in 2015 at Bina Eye Hospital, Tehran, Iran. 
Diagnosis of keratoconus was established (using an 
Orbscan IIz Topographer, Bausch & Lomb, Claremont, CA) 
by a combination of computerized videokeratography 
readings of the anterior and posterior corneal surfaces 
and corneal pachymetry. High myopia was defined as 
myopia ≥ 6.00 D. After the purpose of the study and the 
procedures that would be involved were fully explained, 
all patients were asked to sign an informed consent form 
before being enrolled into the study. The inclusion 
criteria were the presence of poor visual acuity with 
glasses, contact lens intolerance, a clear central cornea, a 
minimum corneal thickness of 360 µm (19, 21, 22), and a 
mean keratometry reading of 45 – 52 D. The exclusion 
criteria were a positive pregnancy test, breastfeeding, 
use of immunosuppressive drugs, previous 
keratorefractive surgery on the eye to be operated on, 
having a history of vernal or atopic keratoconjunctivitis 
or a corneal stromal disorder, and having dry eye 
syndrome, nystagmus, hyperopia, and a severe ocular 
(e.g., herpes keratitis, glaucoma, cataracts, diabetic 
retinopathy, age-related macular degeneration) or 
systemic disease (e.g., an autoimmune disease or a 
systemic connective tissue disease). 
Assessments 
The preoperative assessments involved UDVA, CDVA, and 
manifest refraction assessments and keratometry 
readings. The same assessments were carried out at 3 
months after surgery. Visual acuity was measured using a 
Snellen chart, and transformed into a Logarithm of the 
Minimum Angle of Resolution (logMAR) value for 
statistical analysis, and corneal topography was 
measured using the Orbscan IIz Topographer. 
Surgical Procedure 
The same surgeon (KHJ) performed all the surgeries 
under sterile conditions with topical anesthesia (0.5% 
proparacaine hydrochloride solution). The appropriate 
MyoRing diameter (5- or 6-mm diameter) and thickness 
was selected in accordance with innovative guidelines 
developed based on the authors’ experiences (Fig. 1), 
and then the MyoRing was implanted into the eye. 
The use of the Pocket Maker microkeratome (DIOPTEX 
GmbH) has been described in detail previously (23, 24). 
In brief, an intrastromal pocket, 9 mm in diameter and 
300 µm in depth, was created using a small incision. The 
MyoRing implant was then placed into the pocket using 
implantation forceps, and its position was adjusted using 
a keratoscope. The pocket was self-sealing and did not 
require suturing (21). No intraoperative complications 
occurred. Subsequently, a PureVision silicone hydrogel 
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bandage contact lens (Bausch & Lomb) was placed on the 
cornea and then removed 1 day after the surgery. 
Postoperative treatment comprised betamethasone 
drops (Sina Darou Laboratories, Tehran, Iran) four times 
a day, chloramphenicol drops (Sina Darou Laboratories, 
Tehran, Iran) four times a day, and preservative-free 
artificial tears (Artelac Rebalance, Bausch & Lomb, Inc., 
North Bridgewater, NJ, USA) six times a day. The 
chloramphenicol drops were discontinued 1 week after 
the surgery, while the betamethasone dosage was 
tapered over a period of 4 to 6 weeks. 
 
Figure 1. Guidelines for the selection of MyoRings for patients with keratoconus 
Statistical Analysis 
The categorical variables (sex and number of right and 
left eyes) are expressed as frequencies (with 
percentages). The continuous variables (age and the pre- 
and postoperative UDVA, CDVA, sphere, cylinder, 
spherical equivalent, Kmax, Kmin, and Kmean measurements) 
are expressed as means (with standard deviations). The 
differences between the preoperative and postoperative 
measurements (i.e., UDVA, CDVA, sphere, cylinder, 
spherical equivalent, Kmax, Kmin, and Kmean measurements) 
were compared using paired t-tests. For the between-
group analysis (which compared the outcomes of the 
patients treated with 5- versus 6-mm-diameter 
MyoRings), the continuous variables (UDVA, CDVA, 
sphere, cylinder, and spherical equivalent) are expressed 
as medians (with 25th and 75th percentiles), and the 
between-group differences were compared using Mann–
Whitney U tests. The statistical analysis was performed 
using SPSS for Windows (version 18; SPSS Inc., Chicago, 
IL), and p values < 0.05 were considered statistically 
significant. 
RESULTS 
The study was conducted on 14 men (43.8%) and 18 
women (56.2%). The mean age was 29.6 ± 6.7 years 
(range: 20 – 44) (Table 1). Of the 32 participants, 19 had 
keratoconus in the left eye, and 13 had keratoconus in 
the right eye (Table 1). 
Table 1. Characteristics of Participants, No. = 32 
Variable Values 
Gender  
Male 14 (43.8%) 
Female 18 (56.3 %) 
Age 29.6 ± 6.7 
Range 20–44 
Number of eyes  
Right 13 (40.62) 
Left 19 (59.37) 
SD: standard deviation. 
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The mean pre- and postoperative UDVA, CDVA, spherical 
equivalent, cylinder, sphere, and keratometry readings 
are presented in Table 2. The mean preoperative UDVA 
was 1.14 ± 0.32 logMAR, which improved to 0.35 ± 0.24 
logMAR at 3 months after surgery (< 0.001), and the 
mean preoperative CDVA was 0.47 ± 0.20 logMAR, which 
improved to 0.22 ± 0.15 logMAR after surgery (< 0.001). 
The mean preoperative spherical equivalent was -10.51 ± 
2.81 D, which decreased to -1.32 ± 2.29 D after surgery. 
The mean preoperative cylinder was -4.59 ± 1.86 D, 
which decreased to -2.00 ± 1.51 D after surgery. In 
particular, the mean sphere was considerably reduced by 
-0.32 ± 2.15 D from -8.18 ± 2.58 D. Furthermore, the 
mean keratometry reading was 51.06 ± 3.26 D, which 
decreased to 47.51 ± 3.57 D after surgery.  
 
Table 2. Comparisons of Pre- and Postoperative Visual Acuity, Refractive and keratometric variables 
Variable Preoperative values Postoperative values P value 
UDVA (logMAR)    
Mean ± SD 1.14 ± 0.32 0.35 ± 0.24 < 0.001 
Range 0.40, 1.6 0.0, 1.0  
CDVA (logMAR)    
Mean ± SD 0.47 ± 0.20 0.22 ± 0.15 < 0.001 
Range 0.1, 1.0 0.0, 0.7  
Sphere(D)    
Mean ± SD -8.18 ± 2.58 -0.32 ± 2.15 < 0.001 
Range -15, -6 -5.5, 3.5  
Cylinder(D)    
Mean ± SD -4.59 ± 1.86 -2.00 ± 1.51 < 0.001 
Range -9.5, -0.6 -5.0, 1.5  
Spherical equivalent(D)    
Mean ± SD -10.51 ± 2.81 -1.32 ± 2.29 < 0.001 
Range -17.37, -6.3 -7.0, 2.25  
Kmax(D) 53.62 ± 3.57 48.96 ± 3.55 < 0.001 
Kmin(D) 48.58 ± 3.16 46.15 ± 3.78 < 0.001 
Kmean(D) 51.06 ± 3.26 47.51 ± 3.57 < 0.001 
 
UDVA: uncorrected distance visual acuity, logMAR: 
Logarithm of the Minimum Angle of Resolution, CDVA: 
corrected distance visual acuity, D: diopter, Kmax: 
maximum keratometry value in D, Kmin: minimum 
keratometry value in D, Kmean: mean keratometry value in 
D. Based on the previously mentioned guidelines, a 5-
mm-diameter MyoRing was used for 21 eyes (65.6%) and 
a 6-mm-diameter MyoRing was used for the remaining 
11 eyes. The between-group differences in the median 
changes at 3 months after surgery in sphere and 
spherical equivalent were significant (Table 3). The 
median change in sphere for the 5- and 6-mm-diameter 
MyoRing groups was 8.5 and 6 D, respectively (P = 
0.027), and the median change in spherical equivalent for 
the 5- and 6-mm-diameter MyoRing groups was 10 and 7 
D, respectively (P = 0.027). However, the between-group 
differences in the median changes in UDVA, CDVA, and 














Table 3. Comparison of visual acuity and refractive variables between the 5- and 6-mm-diameter MyoRing groups 
MyoRing diameter(mm) Median (25th and 75th percentiles) P value 
Spherical equivalent(D)   0.024 
5 10 (7.08, 12.25)  
6 7 (6.0,9.25)  
UDVA (logMAR)  0.968 
5 -0.90 (-1.15, -0.3)  
6 -0.85 (1.00,0.6)  
CDVA (logMAR)  0.216 
5 -0.3 (-0.4, -0.1)  
6 0.25 (0.3, 0.0)  
Sphere (D)  0.027 
5 8.5 (6.5, 10.37)  
6 6 (5.25, 7.5)  
Cylinder (D)  0.750 
5 3 (0.87, 4.62)  
6 2 (1.00, 3.50)  
UDVA: uncorrected distance visual acuity, logMAR: Logarithm of the Minimum Angle of Resolution, CDVA: corrected distance visual 
acuity, D: diopter 
DISCUSSION 
This study evaluated the effect of MyoRing implantation 
in patients with keratoconus and high myopia 3 months 
after surgery. We found a remarkable improvement in 
the UDVA, CDVA, spherical equivalent, sphere, and 
cylinder, and the postoperative sphere was considerably 
reduced. We believe that these positive outcomes were 
partly the result of our newly developed guidelines for 
the selection of MyoRings for patients with keratoconus 
(Fig. 1). The improvements indicate that MyoRing 
implantation is an effective method for treating high 
myopia. The degree of reduction in the sphere was 
consistent with that observed in a similar study by Daxer 
et al. (25), which showed that there was a reduction in 
the sphere from -5.13 ± 4.34 D to 0.10 ± 3.2 D at 1 year 
after MyoRing implantation. In the study by Daxer et al., 
the mean CDVA and UDVA improved from 0.42 (0.40 + - 
0.17 logMAR) to 0.77 (0.12 + - 0.10 logMAR), and from 
0.07 (1.24 +/- 0.35 logMAR) to 0.56 (0.27 + - 0.17 
logMAR), respectively. This change in the mean CDVA 
was greater than that observed in our study (from 0.47 
to 0.22 logMAR), which could be due to the shorter 
follow-up period in our study. However, previous 
research on the implantation of intrastromal corneal ring 
segments indicated that here was stability in the 
refraction and visual acuity outcomes between 3 and 6 
months after surgery (26, 27). Nevertheless, there are 
significant differences in treatment-related biomechanics 
between intrastromal corneal ring segments, incomplete 
rings, and complete rings (such as the MyoRing) (28). 
The reduction in the mean keratometry value at 3 
months after surgery was statistically significant, which is 
consistent with the results of the study by Daxer et al., 
who observed a significant reduction in the mean 
keratometry value of 48.96 to 43.20 D (25). The spherical 
equivalent in their study improved from -6.27 ± 5.20 D to 
-0.52 ± 3.4D (25), while we observed a decrease in the 
spherical equivalent from -10.51 ± 2.81 D to -1.32 ± 2.29 
D after surgery. Furthermore, we observed a reduction in 
the cylinder of approximately 2.6D after surgery. 
Similarly, the study by Daxer et al. showed that there was 
a reduction in the cylinder from -3.50 to -1.27 D (25). In 
addition, we assessed the influence of the diameter of 
the MyoRing on the outcomes. We found that there was 
a significant relationship between the diameter and the 
median changes in sphere and spherical equivalent, with 
the 5-mm-diameter MyoRing being more effective than 
the 6-mm-diameter MyoRing. However, the baseline 
characteristics of the patients in the 5- and 6-mm-
diameter groups were not identical (as they were non-
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randomly assigned to the two groups based on the 
factors shown in Fig. 1), so these results are not 
conclusive. A potential limitation of our study is the short 
follow-up period. Further studies with longer follow-up 
periods and multi-center collaboration are 
recommended to allow firmer conclusions to be drawn. 
MyoRing implantation not only reduces myopia in 
patients with keratoconus and high myopia, but it also 
improves UDVA, CDVA, spherical equivalent, sphere, 
cylinder, and keratometry readings. MyoRing 
implantation can be considered a safe and effective 
treatment for patients with keratoconus and high 
myopia. 
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